Free Trial

Cytek Biosciences (CTKB) SEC Filings & 10K Form

Cytek Biosciences logo
$5.11
+0.17 (+3.44%)
(As of 11/1/2024 ET)

Recent Cytek Biosciences SEC Filings

DateFilerForm TypeView
09/16/2024
5:26 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:04 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
5:19 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:21 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:22 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:24 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:26 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:28 PM
Cytek Biosciences (Issuer)
Holder Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:15 PM
Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:16 PM
Cytek Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
3:16 PM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
5:51 PM
Cytek Biosciences (Issuer)
HARDISON DON M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:53 PM
Cytek Biosciences (Issuer)
Imper Vera (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:59 PM
Cytek Biosciences (Issuer)
NEFF DEBORAH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:03 PM
Ball Jack (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:05 PM
Cytek Biosciences (Issuer)
Holder Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/07/2024
6:09 PM
Cytek Biosciences (Issuer)
Holder Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:48 PM
Cytek Biosciences (Filer)
Form SD
Specialized Disclosure Report  
05/22/2024
5:36 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:41 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:28 PM
Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:31 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:32 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:34 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:19 PM
Cytek Biosciences (Issuer)
McCombe William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
3:26 PM
Cytek Biosciences (Filer)
Form ARS
04/23/2024
5:07 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
5:17 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:21 PM
Cytek Biosciences (Subject)
Yan Ming (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2024
5:19 PM
Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:27 PM
Cytek Biosciences (Issuer)
McCombe William D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2024
5:25 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:35 PM
Cytek Biosciences (Subject)
Yan Ming (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
5:53 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:55 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:44 PM
Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:48 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:50 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:39 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:42 PM
Cytek Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
5:44 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

03/08/2024
5:46 PM
Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:47 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:49 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:51 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:52 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:05 PM
Cytek Biosciences (Filer)
Form NT 10-K
03/01/2024
5:06 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:06 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:07 PM
Cytek Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
02/22/2024
4:37 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:46 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:49 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:50 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:32 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:34 PM
Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:12 PM
BROWN CAPITAL MANAGEMENT LLC (Filed by)
Cytek Biosciences (Subject)
Form SC 13G
01/23/2024
3:13 PM
BlackRock Inc. (Filed by)
Cytek Biosciences (Subject)
Form SC 13G/A
01/09/2024
5:05 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
4:36 PM
Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:35 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:28 PM
Cytek Biosciences (Subject)
Yan Ming (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
6:00 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
7:48 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
7:53 PM
Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:56 PM
Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:59 PM
Cytek Biosciences (Issuer)
Yan Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:46 PM
Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:48 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:52 PM
Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:54 PM
Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:39 PM
Cytek Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
5:06 AM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
5:03 PM
Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
3:45 PM
Cytek Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTKB) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners